Exact Mass: 554.3355696

Exact Mass Matches: 554.3355696

Found 30 metabolites which its exact mass value is equals to given mass value 554.3355696, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Notoginsenoside R10

1-(5,16-dihydroxy-2,6,6,10,11-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl)ethan-1-one

C30H50O9 (554.345465)


Notoginsenoside R10 is found in tea. Notoginsenoside R10 is a constituent of Panax notoginseng (sanchi) roots. Constituent of Panax notoginseng (sanchi) roots. Notoginsenoside R10 is found in tea.

   

16,17-dihydro-homobatrachotoxin|3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta,17xiH)-14beta,13-[1]oxa[4]azapentano-18-nor-pregn-7-en-3beta,11alpha-diol|Homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-16,17-dihydro-batrachotoxinin-A

16,17-dihydro-homobatrachotoxin|3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta,17xiH)-14beta,13-[1]oxa[4]azapentano-18-nor-pregn-7-en-3beta,11alpha-diol|Homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-16,17-dihydro-batrachotoxinin-A

C32H46N2O6 (554.3355696)


   

1-O-(24-deoxycholyl)-beta-D-galactopyranose

1-O-(24-deoxycholyl)-beta-D-galactopyranose

C30H50O9 (554.345465)


   

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

C26H50O12 (554.3302100000001)


   

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based on: CCMSLIB00000847525]

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based on: CCMSLIB00000847525]

C26H50O12 (554.3302100000001)


   

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based: Match]

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based: Match]

C26H50O12 (554.3302100000001)


   

VNLPI

Val Asn Leu Pro Ile

C26H46N6O7 (554.3427806)


   

Notoginsenoside R10

1-(5,16-dihydroxy-2,6,6,10,11-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl)ethan-1-one

C30H50O9 (554.345465)


   

RTA-408

Omaveloxolone

C33H44F2N2O3 (554.3319818)


C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent

   

beta-D-galactosyl-deoxycholate

beta-D-galactosyl-deoxycholate

C30H50O9 (554.345465)


   

beta-D-galactosyl-chenodeoxycholate

beta-D-galactosyl-chenodeoxycholate

C30H50O9 (554.345465)


   

3alpha-Glc-CDCA

3alpha-Glc-CDCA

C30H50O9 (554.345465)


   

[3-Hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

[3-Hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

C26H50O12 (554.3302100000001)


   

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

C31H43FN4O4 (554.326817)


   

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

C31H43FN4O4 (554.326817)


   

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

C31H43FN4O4 (554.326817)


   

1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

C31H43FN4O4 (554.326817)


   

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

C31H43FN4O4 (554.326817)


   

Mgdg O-16:4_5:0

Mgdg O-16:4_5:0

C30H50O9 (554.345465)


   

Mgdg O-18:4_3:0

Mgdg O-18:4_3:0

C30H50O9 (554.345465)


   

PA(27:5)

PA(16:1(1)_11:4)

C30H51O7P (554.3372225999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   

ST 24:0;O3;GlcA

ST 24:0;O3;GlcA

C30H50O9 (554.345465)


   
   

1-[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C30H50O9 (554.345465)


   

2-hydroxy-6-(16-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecyl)benzoic acid

2-hydroxy-6-(16-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecyl)benzoic acid

C30H50O9 (554.345465)